Globus Medical, Inc. (GMED)

Globus Medical Stock Forecast

Stock Price Forecast

The 13 analysts that cover Globus Medical stock have a consensus rating of "Buy" and an average price target of $97.15, which forecasts a 11.09% increase in the stock price over the next year. The lowest target is $64 and the highest is $115.

Price Target: $97.15 (+11.09%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$64	$97.15	$100	$115
Change	-26.82%	+11.09%	+14.35%	+31.50%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	3	5	6	6	6
Buy	5	5	5	5	5	5
Hold	5	6	4	5	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	14	14	16	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Saxon Needham	Needham	Hold → Strong Buy Upgrades $112	Hold → Strong Buy	Upgrades	$112	+28.07%	Jan 30, 2026
Caitlin Cronin Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $105 → $112	Strong Buy	Maintains	$105 → $112	+28.07%	Jan 9, 2026
Matt O'Brien Piper Sandler	Piper Sandler	Buy Reiterates $90 → $115	Buy	Reiterates	$90 → $115	+31.50%	Jan 8, 2026
Caitlin Cronin Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $90 → $105	Strong Buy	Maintains	$90 → $105	+20.07%	Dec 17, 2025
Shagun Singh RBC Capital	RBC Capital	Buy Maintains $92 → $100	Buy	Maintains	$92 → $100	+14.35%	Dec 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.97B

Increased by 17.81%

from 2.52B

Revenue Next Year

3.22B

Increased by 8.52%

from 2.97B

EPS This Year

3.92

Increased by 422.03%

from 0.75

EPS Next Year

4.30

Increased by 9.82%

from 3.92

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	789.04M	958.10M	1.02B	1.57B	2.52B	2.97B	3.22B
Revenue Growth	0.47%	21.43%	6.76%	53.35%	60.62%	17.81%	8.52%
EPS	1.01	1.44	1.85	1.07	0.75	3.92	4.30
EPS Growth	-33.55%	42.57%	28.47%	-42.16%	-29.91%	422.03%	9.82%
Forward PE	-	-	-	-	-	22.34	20.34
No. Analysts	-	-	-	-	-	16	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	3.1B	3.4B
Avg	3.0B	3.2B
Low	2.8B	3.0B

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	22.4%	13.8%
Avg	17.8%	8.5%
Low	12.0%	1.5%

EPS Forecast

EPS	2025	2026	2027	2028
High	4.17	4.62
Avg	3.92	4.30
Low	3.68	3.77

EPS Growth

EPS Growth	2025	2026	2027	2028
High	455.8%	18.0%
Avg	422.0%	9.8%
Low	391.3%	-3.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.